Litigation Guides
Exposure to PFAS chemicals, notably PFOA and PFOS in AFFFs, has been linked to different cancers. Presently, there's a moderate correlation between PFOA exposure and kidney cancer, and PFAS exposure and testicular cancer. However, establishing a causal link requires additional evidence.
Medically Reviewed
Aqueous Film-Forming Foams (AFFFs) are specialized firefighting foams specifically designed to extinguish fires, especially those involving highly flammable liquids. They possess unique properties:1,2,3
Historically, many AFFFs contain chemicals called PFASs (per- and polyfluoroalkyl substances).2
PFASs are human-made chemicals containing fluorine atoms bonded to a carbon chain. They are persistent and do not break down easily.
There were some associations between the development of different types of cancer and increased exposure to chemicals found in AFFFs.4
There is strong evidence linking exposure to PFOA, found in AFFFs, to kidney cancer, based on multiple studies.4
Some studies have suggested an association between PFAS exposure and testicular cancer in humans.4 However, the evidence is limited. It can be summarized as follows:4,7
There have been no human studies yet that link PFAS to pancreatic cancer. The evidence is limited to animal and cell studies, as follows:8,9,10
No studies have yet established a direct link between PFAAs and the development of prostate cancer in humans. However, a 2014 study did find a correlation between certain PFAAs and an increased risk of hereditary prostate cancer, as described below:2
The clinical studies reviewed had potential biases and weaknesses that limit the conclusions that can be drawn. Examples of biases and weaknesses include:4
Another study examined cancer rates in 32,254 patients from a community exposed to PFOA in drinking water, where PFOA, also prevalent in aqueous film-forming foams (AFFFs) used in firefighting, is a concerning environmental contaminant.5
However, the study had limitations, including:5
We help attorneys access the latest legal research, medical record reviews, physician consultations, and world-class experts.
The use of PFOS and PFOA has raised environmental and health concerns leading to regulatory action.2,3
Some lab animal studies have demonstrated a causal link between exposure to chemicals found in AFFFs and certain cancers, but the relevance to human disease is uncertain.
1.
Rotander, A., Toms, LM. L., et al. (2015). Elevated levels of PFOS and PFHxS in firefighters exposed to aqueous film forming foam (AFFF). Environment International, 82: 28-34. https://www.sciencedirect.com/science/article/pii/S0160412015001117?via%3Dihub
2.
Hardell, E., Karrman, A., et al. (2014). Case-control study on perfluorinated alkyl acids (PFAAs) and the risk of prostate cancer. Environment International, 63: 35-39. https://www.sciencedirect.com/science/article/pii/S0160412013002201?via%3Dihub
3.
Laitinen, J. A., Koponen, J., et al. (2014). Firefighters’ exposure to perfluoroalkyl acids and 2-butoxyethanol present in firefighting foams. Toxicology Letters, 231: 227-232. https://www.sciencedirect.com/science/article/pii/S0378427414013307?via%3Dihub
4.
Steenland, K., Winquist, A. (2021). PFAS and cancer, a scoping review of the epidemiologic evidence. Environmental Research, 194, 110690. https://www.sciencedirect.com/science/article/pii/S0013935120315899?via%3Dihub
5.
Perfluorooctanoic Acid (PFOA) Exposures and Incident Cancers among Adults Living Near a Chemical Plant. (2013). Retrieved July 27, 2021, from Environmental Health Perspectives website: https://ehp.niehs.nih.gov/doi/full/10.1289/ehp.1306615
6.
Raleigh, K. K., Alexander, B. H., Olsen, G. W., Ramachandran, G., Morey, S. Z., Church, T. R., et al. (2014). Mortality and cancer incidence in ammonium perfluorooctanoate production workers. Occupational and Environmental Medicine, 71(7), 500–506. https://doi.org/10.1136/oemed-2014-102109
7.
Kennedy GL, Butenhoff JL, et al. The Toxicology of Perflurooctanoate. Critical Reviews in Toxicology. 2004; 34(4): 351-384. doi: 10.1080/10408440490464705. https://pubmed.ncbi.nlm.nih.gov/15328768/
8.
International Agency for Research on Cancer. (2016). Some chemicals used as solvents and in polymer manufacture. IARC monographs, 110. https://publications.iarc.fr/Book-And-Report-Series/Iarc-Monographs-On-The-Identification-Of-Carcinogenic-Hazards-To-Humans/Some-Chemicals-Used-As-Solvents-And-In-Polymer-Manufacture-2016
9.
Liu, S., Yang, R., et al. (2020). Effects of per- and poly-fluorinated alkyl substances on pancreatic and endocrine differentiation of human pluripotent stem cells. Chemosphere. 254, 126709. https://www.sciencedirect.com/science/article/pii/S0045653520309024?via%3Dihub
10.
Agency for Toxic Substances and Disease Registry. (2018). Toxicological Profile for Perfluoroalkyls. U.S. Department of Health and Human Services. https://www.atsdr.cdc.gov/toxprofiles/tp200.pdf
About the authors
Rena Zheng, MD
Dr. Rena Zheng, MD, combines a rich background in clinical practice with medical research, making her an exceptional contributor to the medical community. Her journey began with a Bachelor’s degree in Biology from Rutgers University, followed by earning her MD from Ross University School of Medicine. Rena’s dedication to medicine is evident from her intensive residency at Nassau University Hospital and Rush University Medical Center, where she gained comprehensive clinical experience.
Currently serving as a Physician Contractor with the Expert Institute, Dr. Zheng has seamlessly transitioned from patient care to the intricacies of medical-legal consulting. Her work, including notable research on podocyte foot processes, showcases her commitment to advancing medical knowledge and her capability to elucidate complex medical concepts. Rena’s unique blend of clinical expertise and research acumen makes her contributions to medical content not just informative, but also engaging and accessible.
Wendy Ketner, M.D.
Dr. Wendy Ketner is a distinguished medical professional with a comprehensive background in surgery and medical research. Currently serving as the Senior Vice President of Medical Affairs at the Expert Institute, she plays a pivotal role in overseeing the organization's most important client relationships. Dr. Ketner's extensive surgical training was completed at Mount Sinai Beth Israel, where she gained hands-on experience in various general surgery procedures, including hernia repairs, cholecystectomies, appendectomies, mastectomies for breast cancer, breast reconstruction, surgical oncology, vascular surgery, and colorectal surgery. She also provided care in the surgical intensive care unit.
Her research interests have focused on post-mastectomy reconstruction and the surgical treatment of gastric cancer, including co-authoring a textbook chapter on the subject. Additionally, she has contributed to research on the percutaneous delivery of stem cells following myocardial infarction.
Dr. Ketner's educational background includes a Bachelor's degree from Yale University in Latin American Studies and a Doctor of Medicine (M.D.) from SUNY Downstate College of Medicine. Moreover, she is a member of the Board of Advisors for Opollo Technologies, a fintech healthcare AI company, contributing her medical expertise to enhance healthcare technology solutions. Her role at Expert Institute involves leveraging her medical knowledge to provide insights into legal cases, underscoring her unique blend of medical and legal acumen.
Join our newsletter to stay up to date on legal news, insights and product updates from Expert Institute.
We're here to help you build a stronger case. Retain a leading expert witness today.
Need your medical records reviewed? Consult one of our 75+ on-staff physicians who can help evaluate the strengths and weaknesses of your case.